ShareValue scores for HLS.AU: Valuation 62, Quality 62, Growth 35, Health 47.

HLS.AU
ASX

Healius Ltd

A$0.42(+1.20%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
62
Fair Value
Price vs Value
Quality
62
Moderate
Business Strength
Growth
35
Weak
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
22
Bearish
Price Trend

Company Details

About

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026